Coraline Bence
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 20, 2019
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.
Journal: Journal of visualized experiments : JoVE
Published: October 16, 2018
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 06, 2018
Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.
Journal: Clinical chemistry and laboratory medicine
Published: August 26, 2017
Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities.
Journal: Current molecular medicine
Published: July 23, 2017
PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?
Journal: Annales de pathologie
Published: October 24, 2016
High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
Journal: Cancer medicine
Published: July 11, 2015
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 22, 2015
Last Updated: 09/26/2026